title: Vemurafenib sensitivity skin reaction after ipilimumab.
authors.forename: James J
authors.initials: JJ
authors.lastname: Harding
authors.forename: Melissa
authors.initials: M
authors.lastname: Pulitzer
authors.forename: Paul B
authors.initials: PB
authors.lastname: Chapman
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy / Q000235:genetics / Q000556:secondary; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007211:Indoles; D000074324:Ipilimumab; D013449:Sulfonamides; D000077484:Vemurafenib